Eventide Asset Management, LLC Royalty Pharma PLC Transaction History
Eventide Asset Management, LLC
- $5.22 Billion
- Q4 2024
A detailed history of Eventide Asset Management, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Eventide Asset Management, LLC holds 823,390 shares of RPRX stock, worth $27.8 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
823,390
Previous 772,623
6.57%
Holding current value
$27.8 Million
Previous $21.9 Million
3.9%
% of portfolio
0.4%
Previous 0.39%
Shares
9 transactions
Others Institutions Holding RPRX
# of Institutions
431Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.34 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$777 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$573 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$477 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...